Showing 113 of 113on this page. Filters & sort apply to loaded results; URL updates for sharing.113 of 113 on this page
Cd20 | Roche | Bioz
5 Anti - CD20 + Kinase Inhibitor Combination Therapy is the Future
FDA approves Roche’s CD20 antibody Gazyva for lupus nephritis
Structure of CD20 in complex with the therapeutic monoclonal antibody ...
Anti Cd20 | Ventana Medical | Bioz
Tumor cells indicate a positive immunohistochemical reaction with CD20 ...
CD20 Monoclonal Antibody (2H7), eBioscience™ | Invitrogen (14-0209-82)
Regulation of CD20 in Rituximab-Resistant Cell Lines and B-cell Non ...
Immunohistochemical analysis of CD20. (A) CD20 positive cells in a ...
Rituximab Cd20
Multiple Sclerosis Research: CD20 antibodies deplete EBV
CD20 X CD3双特异抗体格局 近日， Genmab 和艾伯维宣布其靶向CD20xCD3的双特异抗体epcoritamab（GEN3013 ...
CD20 Monoclonal Antibody (L26) | Invitrogen (MA5-13141)
CD20 Antibody (MA5-16334)
Increasing the efficacy of CD20 antibody therapy through the ...
CD20 target coverage in B-cells and according to CD21+ status ...
Rituximab and the CD20 antigen. Panel A. Rituximab Structure. Panel B ...
Detection of CD20 by immunohistochemical stains using L26 MoAb. L26 is ...
Anti-CD20 CAR-T Cells CD20 78611
CD20 Monoclonal Antibody (L26), eBioscience™ | Invitrogen (14-0202-82)
Human CD20 Antibody (Obinutuzumab, Research Use)
Reactivity to CD20 (a) and CD3 (b) showed a reactive pattern of the ...
An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger ...
CD20 Monoclonal Antibody (L26) (A500-017A)
Roche on LinkedIn: We are pleased to present new data for two novel ...
CD20 Monoclonal Antibody (L26), Alexa Fluor™ 488 (53-0202-82)
Immunohistochemistry (×400) showing CD20 positive small lymphocytes ...
Immunohistochemistry: large cells showing positive staining for CD20 ...
CD20 Monoclonal Antibody (L26), eFluor™ 660, eBioscience™ | Invitrogen ...
CD20 Monoclonal Antibody (L26) (14-0202-82)
Research Progress on CD20 in Autoimmune Diseases-DIMA BIOTECH
CD20 Antibody (14-0202-82)
Immunohistochemistry results demonstrating CD20 expression in the ...
Immunohistochemical staining for CD20 showing diffusely positive ...
CD20 Monoclonal Antibody (QCH6A7), Brilliant Ultra Violet™ 661 (376 ...
CD20：从Chimeric，Humanized，Afucosylated到T-cell Engager，终点是Roche - 知乎
双特异性抗体研发成热门 艾伯维(ABBV.US)、罗氏(RHHBY.US)、赛诺菲(SNY.US)已入局_凤凰网
Roche's Mosunetuzumab Approved for FL in China
Roche’s follicular lymphoma drug, 1st to receive approval through fast ...
Genentech Announces New Data on Novel CD20-CD3 Bispecific Cancer ...
罗氏为什么开发了两款成功的CD3xCD20双抗？ - 知乎
CAR-T强力对手!罗氏CD3/CD20双抗glofitamab获CDE优先审评，治疗LBCL - 知乎
深化布局：罗氏第 2 款 CD3/CD20 双抗在美国获批上市_Insight_治疗_疗法
刚刚！罗氏CD20单抗首个非肿瘤适应症获批 2025年10月20日，Roche宣布，基于其重磅抗CD20 单抗Gazyva/Gazyvaro ...
Roche’s Glofitamab.pdf
CD20xCD3双抗梳理 近日，罗氏宣布FDA已接受其CD20xCD3双抗Mosunetuzumab（Lunsumio®）治疗非霍奇金淋巴瘤的 ...
首款CD20xCD3双特异性抗体！欧盟批准罗氏Lunsumio：治疗滤泡性淋巴瘤(FL)，完全缓解率达60%_凤凰网
罗氏CD3/CD20双抗中国申报上市 Armstrong 2023年2月1日，罗氏格罗菲妥单抗（Glofitamab）注射液的上市申请获得 ...
Frontiers | Advancements in cancer immunotherapies targeting CD20: from ...
Roche's CD3/CD20 Bispecific Antibody Faces Setback
全球获批的10款双抗全梳理|CD20|ORR|CD3|双抗|细胞|抗体|靶向|-健康界
记住所有FDA生物药 | 两款CD20 x CD3双抗 | Mosunetuzumab、Glofitamab | B细胞淋巴瘤 - 知乎
CD20-Targeting Antibodies Are Shaping a New Landscape for B-Cell Cancers
Odronextamab, a human CD20×CD3 bispecific antibody in patients with ...
Therapeutic potential of CD20/CD3 bispecific antibodies i...
Development of a bicistronic anti-CD19/CD20 CAR construct including ...
IJMS | Free Full-Text | Promising Immunotherapeutic Modalities for B ...
CD20, Why is It Such Popular in Antibody Drug Development?-CUSABIO
Top 5 Companies Developing Bispecific Antibodies
Isolation of a mouse CD20-specific monoclonal antibody that can ...
FDA整治药企拖延症，暂缓第四款CD3×CD20双抗上市 - 知乎
记住所有FDA生物药 | 靶向CD20 | Ocrevus®Ocrelizumab | 多发性硬化 MS - 知乎
Multiplex Immunohistochemistry and Immunofluorescence: A Practical ...
罗氏CD20/CD3双抗格罗菲妥单抗注射液在中国获批,治疗弥漫大B细胞淋巴瘤
CONFIRM anti-CD20 (L26) Primary Antibody
CD20, Brilliant Therapeutic Target in Multiple Indications
Tracking Roche’s next-gen anti-CD20 launch | MDDetails
Subcutaneous versus Intravenous Administration of Rituximab ...
Immunohistochemical study for CD20. All case demonstrated positive ...
Immunohistochemistry for CD20+ (B lymphocytes), (brown, × 100 ...
罗氏宣布CD20/CD3双特异性抗体在加拿大获批，惠及多种淋巴瘤患者 加拿大时间3月25日，罗氏（Roche）宣布，双特异性抗体Columvi ...
技术平台
FDA 核准羅氏紅斑性狼瘡腎炎新藥，全球 170 萬患者新希望 | GeneOnline News
Immunohistochemical detection of CD20+ lymphocytes with intracellular ...
Frontiers | Anti-CD20 therapies in multiple sclerosis: From pathology ...
今日，罗氏旗下基因泰克宣布CD20/CD3双抗在美国获批 美国东部时间6月15日，罗氏（Roche）旗下基因泰克（Genentech）宣布 ...
Dual targeting of CD19 and CD22 against B-ALL using a novel high ...
Immunohistochemistry stain (CD20) The image demonstrates diffuse ...
The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 ...
Immunohistochemical analysis and quantification of CD20-positive cells ...
Frontiers | Therapeutic Antibodies: What Have We Learnt from Targeting ...
Immunohistochemistry of case 2. There is a much more prominent ...
Representative immunohistochemistry images for B-cells (CD20þ) from the ...
Full article: Highly potent anti-CD20-RLI immunocytokine targeting ...
罗氏CD20 /CD3双抗mosunetuzumab在中国拟纳入优先审评，治疗滤泡性淋巴瘤
Rituximab
CD3 bispecific antibody–induced cytokine release is dispensable for ...
Key characteristics of anti-CD20 monoclonal antibodies and clinical ...
Obinutuzumab auf der Überholspur | PZ – Pharmazeutische Zeitung
Immunohistochemistry showing CD20-positive B-cells in the lymphoid ...
Immunohistochemistry
Immunohistochemistry stain for CD20, light microscopy 10 × 4 ...
Emerging bispecific antibodies in cancer immunotherapy
Armstrong生物药资讯 : 全球首款：博锐生物CD3/CD19/CD20三抗获批中国临床-博锐生物 BioRay
